DK1032390T3 - Anæstetisk formulering - Google Patents

Anæstetisk formulering

Info

Publication number
DK1032390T3
DK1032390T3 DK98954639T DK98954639T DK1032390T3 DK 1032390 T3 DK1032390 T3 DK 1032390T3 DK 98954639 T DK98954639 T DK 98954639T DK 98954639 T DK98954639 T DK 98954639T DK 1032390 T3 DK1032390 T3 DK 1032390T3
Authority
DK
Denmark
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anesthetic formulation
Prior art date
Application number
DK98954639T
Other languages
Danish (da)
English (en)
Inventor
Stephen Brown
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of DK1032390T3 publication Critical patent/DK1032390T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK98954639T 1997-11-19 1998-11-19 Anæstetisk formulering DK1032390T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation
PCT/GB1998/003479 WO1999025349A1 (en) 1997-11-19 1998-11-19 Anaesthetic formulation

Publications (1)

Publication Number Publication Date
DK1032390T3 true DK1032390T3 (da) 2004-03-15

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98954639T DK1032390T3 (da) 1997-11-19 1998-11-19 Anæstetisk formulering

Country Status (18)

Country Link
US (1) US5932597A (pt)
EP (1) EP1032390B1 (pt)
JP (1) JP2001522888A (pt)
KR (1) KR100695588B1 (pt)
CN (1) CN1131033C (pt)
AT (1) ATE253913T1 (pt)
AU (1) AU740914B2 (pt)
BR (1) BR9814883A (pt)
CA (1) CA2308495C (pt)
DE (1) DE69819770T2 (pt)
DK (1) DK1032390T3 (pt)
ES (1) ES2209217T3 (pt)
HK (1) HK1026848A1 (pt)
HU (1) HU228143B1 (pt)
IL (1) IL135922A0 (pt)
NO (1) NO328684B1 (pt)
PT (1) PT1032390E (pt)
WO (1) WO1999025349A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4865330B2 (ja) 2002-12-13 2012-02-01 デュレクト コーポレーション 経口ドラッグデリバリーシステム
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
EP3331508B1 (en) * 2015-07-13 2024-08-14 Neon Laboratories Ltd. Hyperbaric solution injection of levobupivacaine hydrochloride comprising levobupivacaine hydrochloride
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
CN1074920C (zh) * 1993-10-13 2001-11-21 达尔文发现有限公司 止痛剂及其应用

Also Published As

Publication number Publication date
HK1026848A1 (en) 2000-12-29
DE69819770D1 (de) 2003-12-18
AU740914B2 (en) 2001-11-15
US5932597A (en) 1999-08-03
NO20002545L (no) 2000-05-18
HUP0004665A3 (en) 2004-05-28
WO1999025349A1 (en) 1999-05-27
HUP0004665A2 (hu) 2001-04-28
JP2001522888A (ja) 2001-11-20
KR20010032241A (ko) 2001-04-16
CA2308495C (en) 2009-01-06
EP1032390B1 (en) 2003-11-12
ES2209217T3 (es) 2004-06-16
AU1168499A (en) 1999-06-07
NO328684B1 (no) 2010-04-26
CA2308495A1 (en) 1999-05-27
CN1279607A (zh) 2001-01-10
CN1131033C (zh) 2003-12-17
DE69819770T2 (de) 2004-09-23
HU228143B1 (en) 2012-12-28
IL135922A0 (en) 2001-05-20
ATE253913T1 (de) 2003-11-15
KR100695588B1 (ko) 2007-03-14
BR9814883A (pt) 2000-10-03
NO20002545D0 (no) 2000-05-18
PT1032390E (pt) 2004-04-30
EP1032390A1 (en) 2000-09-06

Similar Documents

Publication Publication Date Title
DK1032390T3 (da) Anæstetisk formulering
BR0214184A (pt) Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
DK1068870T3 (da) Antitumormidler
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
ATE367097T1 (de) Verwendung von füllstoffe als sättigungsmittel
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
AU2003298179A1 (en) Lens care composition and method
HUP0203773A2 (hu) Epinastintartalmú oldatok
ES2182255T3 (es) Agente de blanqueo fluorescente.
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
DK1167354T3 (da) Racemisk huperzin A
JP2001522888A5 (pt)
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DE69326840D1 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
DE59813853D1 (de) Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
FI946057A (fi) Paikalliseen käyttöön tarkoitettu valmiste
DE60213464D1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
DE60207824D1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
IT1256441B (it) Composizioni farmaceutiche topiche contro le punture di insetti
RU2002120345A (ru) Средство "пипользин" антигистаминного действия
TH58081B (th) สูตรใช้เฉพาะแห่งไบรวูดีนที่ได้รับการทำให้คงตัว
ATE177631T1 (de) Synergistische malariamittel, die benflumetol enthalten